Which has higher valuation and earnings, HIND or MDAI?

Spectral AI has higher revenue and earnings than Vyome. Spectral AI is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 48.92 -$10.26M -$12.27 N/A Spectral AI $19.65M 2.99 -$7.57M -$0.53 N/A

Is HIND or MDAI more profitable?

Spectral AI has a net margin of -85.58% compared to Vyome's net margin of -270.58%. Spectral AI's return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome -270.58% -203.92% -134.16% Spectral AI -85.58% N/A -72.97%

Does the media refer more to HIND or MDAI?

In the previous week, Spectral AI had 1 more articles in the media than Vyome. MarketBeat recorded 4 mentions for Spectral AI and 3 mentions for Vyome. Vyome's average media sentiment score of 1.28 beat Spectral AI's score of 0.60 indicating that Vyome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vyome 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spectral AI 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer HIND or DXR?

Vyome presently has a consensus price target of $15.00, indicating a potential upside of 572.65%. Given Vyome's higher probable upside, equities research analysts clearly believe Vyome is more favorable than Daxor. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable valuation & earnings, HIND or DXR?

Daxor has lower revenue, but higher earnings than Vyome. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 48.92 -$10.26M -$12.27 N/A Daxor N/A N/A N/A N/A N/A

Is HIND or DXR more profitable?

Daxor has a net margin of 0.00% compared to Vyome's net margin of -270.58%. Daxor's return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome -270.58% -203.92% -134.16% Daxor N/A N/A N/A

Do analysts recommend HIND or QTEX?

Vyome presently has a consensus price target of $15.00, suggesting a potential upside of 572.65%. Given Vyome's stronger consensus rating and higher possible upside, analysts plainly believe Vyome is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, HIND or QTEX?

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 48.92 -$10.26M -$12.27 N/A Inspira Technologies OXY B.H.N. $290K 188.68 -$13.22M N/A N/A

Does the media refer more to HIND or QTEX?

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Vyome. MarketBeat recorded 5 mentions for Inspira Technologies OXY B.H.N. and 3 mentions for Vyome. Vyome's average media sentiment score of 1.28 beat Inspira Technologies OXY B.H.N.'s score of 0.47 indicating that Vyome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vyome 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend HIND or IINN?

Vyome currently has a consensus target price of $15.00, suggesting a potential upside of 572.65%. Given Vyome's stronger consensus rating and higher probable upside, equities analysts clearly believe Vyome is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, HIND or IINN?

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 48.92 -$10.26M -$12.27 N/A Inspira Technologies OXY B.H.N. $289K 160.46 -$13.22M N/A N/A

Does the media refer more to HIND or IINN?

In the previous week, Vyome had 2 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for Vyome and 1 mentions for Inspira Technologies OXY B.H.N.. Vyome's average media sentiment score of 1.28 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Vyome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vyome 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, DRIO or HIND?

Vyome has lower revenue, but higher earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DarioHealth $22.36M 2.36 -$41.71M -$8.88 N/A Vyome $320K 48.92 -$10.26M -$12.27 N/A

Is DRIO or HIND more profitable?

DarioHealth has a net margin of -192.23% compared to Vyome's net margin of -270.58%. DarioHealth's return on equity of -60.52% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets DarioHealth -192.23% -60.52% -37.08% Vyome -270.58% -203.92% -134.16%

Vyome (HIND) Competitors

$2.23 -0.07 (-3.04%)

As of 10:11 AM Eastern

Compare

HIND vs. MDAI, DXR, QTEX, IINN, and DRIO

Should you buy Vyome stock or one of its competitors? MarketBeat compares Vyome with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Vyome include Spectral AI (MDAI), Daxor (DXR), Inspira Technologies OXY B.H.N. (QTEX), Inspira Technologies OXY B.H.N. (IINN), and DarioHealth (DRIO). These companies are all part of the "medical equipment" industry.

How does Vyome compare to Spectral AI?

Vyome (NASDAQ:HIND) and Spectral AI (NASDAQ:MDAI) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Spectral AI has a net margin of -85.58% compared to Vyome's net margin of -270.58%. Spectral AI's return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	-270.58%	-203.92%	-134.16%
Spectral AI	-85.58%	N/A	-72.97%

Spectral AI has higher revenue and earnings than Vyome. Spectral AI is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	48.92	-$10.26M	-$12.27	N/A
Spectral AI	$19.65M	2.99	-$7.57M	-$0.53	N/A

22.1% of Vyome shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 33.0% of Vyome shares are held by company insiders. Comparatively, 13.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Vyome presently has a consensus price target of $15.00, indicating a potential upside of 572.65%. Spectral AI has a consensus price target of $4.00, indicating a potential upside of 116.80%. Given Vyome's stronger consensus rating and higher probable upside, equities research analysts clearly believe Vyome is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Spectral AI had 1 more articles in the media than Vyome. MarketBeat recorded 4 mentions for Spectral AI and 3 mentions for Vyome. Vyome's average media sentiment score of 1.28 beat Spectral AI's score of 0.60 indicating that Vyome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vyome	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Vyome has a beta of 1.48, meaning that its share price is 48% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.15, meaning that its share price is 15% more volatile than the broader market.

Summary

Vyome and Spectral AI tied by winning 8 of the 16 factors compared between the two stocks.

How does Vyome compare to Daxor?

Vyome (NASDAQ:HIND) and Daxor (NASDAQ:DXR) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Vyome presently has a consensus price target of $15.00, indicating a potential upside of 572.65%. Given Vyome's higher probable upside, equities research analysts clearly believe Vyome is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

22.1% of Vyome shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 33.0% of Vyome shares are owned by company insiders. Comparatively, 51.5% of Daxor shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Vyome has a beta of 1.48, indicating that its share price is 48% more volatile than the broader market. Comparatively, Daxor has a beta of 0.27, indicating that its share price is 73% less volatile than the broader market.

Daxor has lower revenue, but higher earnings than Vyome.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	48.92	-$10.26M	-$12.27	N/A
Daxor	N/A	N/A	N/A	N/A	N/A

Daxor has a net margin of 0.00% compared to Vyome's net margin of -270.58%. Daxor's return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	-270.58%	-203.92%	-134.16%
Daxor	N/A	N/A	N/A

In the previous week, Vyome had 2 more articles in the media than Daxor. MarketBeat recorded 3 mentions for Vyome and 1 mentions for Daxor. Daxor's average media sentiment score of 1.89 beat Vyome's score of 1.28 indicating that Daxor is being referred to more favorably in the news media.

Company	Overall Sentiment
Vyome	Positive
Daxor	Very Positive

Summary

Vyome and Daxor tied by winning 6 of the 12 factors compared between the two stocks.

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Vyome (NASDAQ:HIND) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap manufacturing companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Vyome's net margin of -270.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	-270.58%	-203.92%	-134.16%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

22.1% of Vyome shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 33.0% of Vyome shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Vyome presently has a consensus price target of $15.00, suggesting a potential upside of 572.65%. Given Vyome's stronger consensus rating and higher possible upside, analysts plainly believe Vyome is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Vyome. MarketBeat recorded 5 mentions for Inspira Technologies OXY B.H.N. and 3 mentions for Vyome. Vyome's average media sentiment score of 1.28 beat Inspira Technologies OXY B.H.N.'s score of 0.47 indicating that Vyome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vyome	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Vyome has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.06, suggesting that its share price is 306% more volatile than the broader market.

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	48.92	-$10.26M	-$12.27	N/A
Inspira Technologies OXY B.H.N.	$290K	188.68	-$13.22M	N/A	N/A

Summary

Vyome beats Inspira Technologies OXY B.H.N. on 8 of the 14 factors compared between the two stocks.

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Vyome (NASDAQ:HIND) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Vyome's net margin of -270.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	-270.58%	-203.92%	-134.16%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

In the previous week, Vyome had 2 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for Vyome and 1 mentions for Inspira Technologies OXY B.H.N.. Vyome's average media sentiment score of 1.28 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Vyome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vyome	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	48.92	-$10.26M	-$12.27	N/A
Inspira Technologies OXY B.H.N.	$289K	160.46	-$13.22M	N/A	N/A

Vyome has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market.

22.1% of Vyome shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 33.0% of Vyome shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Vyome currently has a consensus target price of $15.00, suggesting a potential upside of 572.65%. Given Vyome's stronger consensus rating and higher probable upside, equities analysts clearly believe Vyome is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Vyome beats Inspira Technologies OXY B.H.N. on 9 of the 14 factors compared between the two stocks.

How does Vyome compare to DarioHealth?

DarioHealth (NASDAQ:DRIO) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

Vyome has lower revenue, but higher earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.36	-$41.71M	-$8.88	N/A
Vyome	$320K	48.92	-$10.26M	-$12.27	N/A

DarioHealth currently has a consensus price target of $10.50, indicating a potential upside of 45.65%. Vyome has a consensus price target of $15.00, indicating a potential upside of 572.65%. Given Vyome's stronger consensus rating and higher possible upside, analysts plainly believe Vyome is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 22.1% of Vyome shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 33.0% of Vyome shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

DarioHealth has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, Vyome has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

DarioHealth has a net margin of -192.23% compared to Vyome's net margin of -270.58%. DarioHealth's return on equity of -60.52% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-192.23%	-60.52%	-37.08%
Vyome	-270.58%	-203.92%	-134.16%

In the previous week, Vyome had 2 more articles in the media than DarioHealth. MarketBeat recorded 3 mentions for Vyome and 1 mentions for DarioHealth. Vyome's average media sentiment score of 1.28 beat DarioHealth's score of 0.94 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
DarioHealth	Positive
Vyome	Positive

Summary

Vyome beats DarioHealth on 10 of the 16 factors compared between the two stocks.

Get Vyome News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIND vs. The Competition

Export

Metric	Vyome	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$15.66M	$2.82B	$4.35B	$12.31B
Dividend Yield	N/A	N/A	10.25%	5.66%
P/E Ratio	-0.18	13.72	22.33	24.76
Price / Sales	48.92	63.86	130.36	168.32
Price / Cash	N/A	8.03	40.19	37.92
Price / Book	3.33	5.83	27.52	6.90
Net Income	-$10.26M	$7.39M	$116.61M	$337.45M
7 Day Performance	1.83%	-1.69%	2.54%	2.84%
1 Month Performance	17.99%	-1.53%	2.67%	4.78%
1 Year Performance	N/A	12.97%	15.22%	33.08%

Vyome Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIND Vyome	3.5139 of 5 stars	$2.23 -3.0%	$15.00 +572.6%	N/A	$15.66M	$320K	N/A	50	News Coverage Positive News Short Interest Decrease Gap Down
MDAI Spectral AI	2.3238 of 5 stars	$1.83 -1.6%	$4.00 +118.6%	-7.6%	$59.19M	$19.65M	N/A	83
DXR Daxor	3.3046 of 5 stars	$9.87 -1.3%	N/A	+13.6%	$58.38M	N/A	N/A	37	Positive News Gap Up
QTEX Inspira Technologies OXY B.H.N.	0.3136 of 5 stars	$1.42 -11.3%	N/A	N/A	$57.52M	$290K	N/A	20	News Coverage Gap Up
IINN Inspira Technologies OXY B.H.N.	0.538 of 5 stars	$1.60 +13.5%	N/A	+77.7%	$57.52M	$289K	N/A	20	Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIND) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vyome (HIND) Competitors